A citation-based method for searching scientific literature

Gary Kohanbash, Diego A Carrera, Shruti Shrivastav, Brian J Ahn, Naznin Jahan, Tali Mazor, Zinal S Chheda, Kira M Downey, Payal B Watchmaker, Casey Beppler, Rolf Warta, Nduka A Amankulor, Christel Herold-Mende, Joseph F Costello, Hideho Okada. J Clin Invest 2017
Times Cited: 158







List of co-cited articles
1257 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Prospects of immune checkpoint modulators in the treatment of glioblastoma.
Matthias Preusser, Michael Lim, David A Hafler, David A Reardon, John H Sampson. Nat Rev Neurol 2015
214
5



Beyond Brooding on Oncometabolic Havoc in IDH-Mutant Gliomas and AML: Current and Future Therapeutic Strategies.
Hanumantha Rao Madala, Surendra R Punganuru, Viswanath Arutla, Subhasis Misra, T J Thomas, Kalkunte S Srivenugopal. Cancers (Basel) 2018
22
22

A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation.
Christopher G Duncan, Benjamin G Barwick, Genglin Jin, Carlo Rago, Priya Kapoor-Vazirani, Doris R Powell, Jen-Tsan Chi, Darell D Bigner, Paula M Vertino, Hai Yan. Genome Res 2012
124
5

Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway.
Jun Wei, Jason Barr, Ling-Yuan Kong, Yongtao Wang, Adam Wu, Amit K Sharma, Joy Gumin, Verlene Henry, Howard Colman, Waldemar Priebe,[...]. Mol Cancer Ther 2010
181
5


The movers and shapers in immune privilege of the CNS.
Britta Engelhardt, Peter Vajkoczy, Roy O Weller. Nat Immunol 2017
332
5

What is immune privilege (not)?
Ian Galea, Ingo Bechmann, V Hugh Perry. Trends Immunol 2007
467
5

HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.
Nabil Ahmed, Vita Brawley, Meenakshi Hegde, Kevin Bielamowicz, Mamta Kalra, Daniel Landi, Catherine Robertson, Tara L Gray, Oumar Diouf, Amanda Wakefield,[...]. JAMA Oncol 2017
281
5

Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma.
Christine E Brown, Behnam Badie, Michael E Barish, Lihong Weng, Julie R Ostberg, Wen-Chung Chang, Araceli Naranjo, Renate Starr, Jamie Wagner, Christine Wright,[...]. Clin Cancer Res 2015
298
5

Prognostic significance and mechanism of Treg infiltration in human brain tumors.
Joannes F M Jacobs, Albert J Idema, Kalijn F Bol, J André Grotenhuis, I Jolanda M de Vries, Pieter Wesseling, Gosse J Adema. J Neuroimmunol 2010
135
5

IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism.
Alexandra R Grassian, Seth J Parker, Shawn M Davidson, Ajit S Divakaruni, Courtney R Green, Xiamei Zhang, Kelly L Slocum, Minying Pu, Fallon Lin, Chad Vickers,[...]. Cancer Res 2014
139
5

Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assays.
Daniel J Urban, Natalia J Martinez, Mindy I Davis, Kyle R Brimacombe, Dorian M Cheff, Tobie D Lee, Mark J Henderson, Steven A Titus, Rajan Pragani, Jason M Rohde,[...]. Sci Rep 2017
25
20

Immunosuppressive mechanisms in glioblastoma.
Edjah K Nduom, Michael Weller, Amy B Heimberger. Neuro Oncol 2015
163
5

Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.
Tanner M Johanns, Christopher A Miller, Ian G Dorward, Christina Tsien, Edward Chang, Arie Perry, Ravindra Uppaluri, Cole Ferguson, Robert E Schmidt, Sonika Dahiya,[...]. Cancer Discov 2016
167
5

T-cell Dysfunction in Glioblastoma: Applying a New Framework.
Karolina I Woroniecka, Kristen E Rhodin, Pakawat Chongsathidkiet, Kristin A Keith, Peter E Fecci. Clin Cancer Res 2018
82
6

Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling.
Salvatore J Coniglio, Eliseo Eugenin, Kostantin Dobrenis, E Richard Stanley, Brian L West, Marc H Symons, Jeffrey E Segall. Mol Med 2012
221
5

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity.
Stefani Spranger, Riyue Bao, Thomas F Gajewski. Nature 2015
5

Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas.
P Wang, Q Dong, C Zhang, P-F Kuan, Y Liu, W R Jeck, J B Andersen, W Jiang, G L Savich, T-X Tan,[...]. Oncogene 2013
243
5

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Martin J van den Bent, Hendrikus J Dubbink, Yannick Marie, Alba A Brandes, Martin J B Taphoorn, Pieter Wesseling, Marc Frenay, Cees C Tijssen, Denis Lacombe, Ahmed Idbaih,[...]. Clin Cancer Res 2010
305
5

The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma.
Fonnet E Bleeker, Nadia A Atai, Simona Lamba, Ard Jonker, Denise Rijkeboer, Klazien S Bosch, Wikky Tigchelaar, Dirk Troost, W Peter Vandertop, Alberto Bardelli,[...]. Acta Neuropathol 2010
197
5

Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation.
Dorota Klysz, Xuguang Tai, Philippe A Robert, Marco Craveiro, Gaspard Cretenet, Leal Oburoglu, Cédric Mongellaz, Stefan Floess, Vanessa Fritz, Maria I Matias,[...]. Sci Signal 2015
195
5

On the origin of cancer cells.
O WARBURG. Science 1956
5

Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.
Chih-Hao Chang, Jing Qiu, David O'Sullivan, Michael D Buck, Takuro Noguchi, Jonathan D Curtis, Qiongyu Chen, Mariel Gindin, Matthew M Gubin, Gerritje J W van der Windt,[...]. Cell 2015
5

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Aleksandra D Eyring, Andrew D Skora, Brandon S Luber, Nilofer S Azad, Dan Laheru,[...]. N Engl J Med 2015
5

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.
Robert J Motzer, Bernard Escudier, David F McDermott, Saby George, Hans J Hammers, Sandhya Srinivas, Scott S Tykodi, Jeffrey A Sosman, Giuseppe Procopio, Elizabeth R Plimack,[...]. N Engl J Med 2015
5

Clonal evolution of glioblastoma under therapy.
Jiguang Wang, Emanuela Cazzato, Erik Ladewig, Veronique Frattini, Daniel I S Rosenbloom, Sakellarios Zairis, Francesco Abate, Zhaoqi Liu, Oliver Elliott, Yong-Jae Shin,[...]. Nat Genet 2016
323
5

Pembrolizumab for the treatment of non-small-cell lung cancer.
Edward B Garon, Naiyer A Rizvi, Rina Hui, Natasha Leighl, Ani S Balmanoukian, Joseph Paul Eder, Amita Patnaik, Charu Aggarwal, Matthew Gubens, Leora Horn,[...]. N Engl J Med 2015
5

Fate mapping analysis reveals that adult microglia derive from primitive macrophages.
Florent Ginhoux, Melanie Greter, Marylene Leboeuf, Sayan Nandi, Peter See, Solen Gokhan, Mark F Mehler, Simon J Conway, Lai Guan Ng, E Richard Stanley,[...]. Science 2010
5

Recurrent Glioblastoma Treated with Recombinant Poliovirus.
Annick Desjardins, Matthias Gromeier, James E Herndon, Nike Beaubier, Dani P Bolognesi, Allan H Friedman, Henry S Friedman, Frances McSherry, Andrea M Muscat, Smita Nair,[...]. N Engl J Med 2018
260
5

2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas.
Changho Choi, Sandeep K Ganji, Ralph J DeBerardinis, Kimmo J Hatanpaa, Dinesh Rakheja, Zoltan Kovacs, Xiao-Li Yang, Tomoyuki Mashimo, Jack M Raisanen, Isaac Marin-Valencia,[...]. Nat Med 2012
474
5

IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors.
Remco J Molenaar, Tomas Radivoyevitch, Yasunobu Nagata, Mohammed Khurshed, Bartolomiej Przychodzen, Hideki Makishima, Mingjiang Xu, Fonnet E Bleeker, Johanna W Wilmink, Hetty E Carraway,[...]. Clin Cancer Res 2018
40
12

D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function.
Masato Sasaki, Christiane B Knobbe, Momoe Itsumi, Andrew J Elia, Isaac S Harris, Iok In Christine Chio, Rob A Cairns, Susan McCracken, Andrew Wakeham, Jillian Haight,[...]. Genes Dev 2012
195
5

Oncometabolites d- and l-2-Hydroxyglutarate Inhibit the AlkB Family DNA Repair Enzymes under Physiological Conditions.
Fangyi Chen, Ke Bian, Qi Tang, Bogdan I Fedeles, Vipender Singh, Zachary T Humulock, John M Essigmann, Deyu Li. Chem Res Toxicol 2017
36
13

Current state of immunotherapy for glioblastoma.
Michael Lim, Yuanxuan Xia, Chetan Bettegowda, Michael Weller. Nat Rev Clin Oncol 2018
336
5

Vaccine-based immunotherapeutic approaches to gliomas and beyond.
Michael Weller, Patrick Roth, Matthias Preusser, Wolfgang Wick, David A Reardon, Michael Platten, John H Sampson. Nat Rev Neurol 2017
70
7

A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment.
Hannah Van Hove, Liesbet Martens, Isabelle Scheyltjens, Karen De Vlaminck, Ana Rita Pombo Antunes, Sofie De Prijck, Niels Vandamme, Sebastiaan De Schepper, Gert Van Isterdael, Charlotte L Scott,[...]. Nat Neurosci 2019
200
5

Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis.
Tyler J Alban, Alvaro G Alvarado, Mia D Sorensen, Defne Bayik, Josephine Volovetz, Emily Serbinowski, Erin E Mulkearns-Hubert, Maksim Sinyuk, James S Hale, Giovana R Onzi,[...]. JCI Insight 2018
58
8

Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma.
Gregor Hutter, Johanna Theruvath, Claus Moritz Graef, Michael Zhang, Matthew Kenneth Schoen, Eva Maria Manz, Mariko L Bennett, Andrew Olson, Tej D Azad, Rahul Sinha,[...]. Proc Natl Acad Sci U S A 2019
82
6

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.
Jan C Buckner, Edward G Shaw, Stephanie L Pugh, Arnab Chakravarti, Mark R Gilbert, Geoffrey R Barger, Stephen Coons, Peter Ricci, Dennis Bullard, Paul D Brown,[...]. N Engl J Med 2016
447
5

Neutrophils promote the malignant glioma phenotype through S100A4.
Ji Liang, Yuji Piao, Lindsay Holmes, Gregory N Fuller, Verlene Henry, Ningyi Tiao, John F de Groot. Clin Cancer Res 2014
122
5

Mutational landscape and clonal architecture in grade II and III gliomas.
Hiromichi Suzuki, Kosuke Aoki, Kenichi Chiba, Yusuke Sato, Yusuke Shiozawa, Yuichi Shiraishi, Teppei Shimamura, Atsushi Niida, Kazuya Motomura, Fumiharu Ohka,[...]. Nat Genet 2015
443
5

Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation.
Jinlong Shi, Baolan Sun, Wei Shi, Hao Zuo, Daming Cui, Lanchun Ni, Jian Chen. Tumour Biol 2015
87
5

Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers.
Dusten Unruh, Makda Zewde, Adam Buss, Michael R Drumm, Anh N Tran, Denise M Scholtens, Craig Horbinski. Sci Rep 2019
19
26

Lactate dehydrogenase A silencing in IDH mutant gliomas.
Charles Chesnelong, Myriam M Chaumeil, Michael D Blough, Mohammad Al-Najjar, Owen D Stechishin, Jennifer A Chan, Russell O Pieper, Sabrina M Ronen, Samuel Weiss, H Artee Luchman,[...]. Neuro Oncol 2014
100
5

Radioprotection of IDH1-Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198.
Remco J Molenaar, Dennis Botman, Myrthe A Smits, Vashendriya V Hira, Sanne A van Lith, Jan Stap, Peter Henneman, Mohammed Khurshed, Krissie Lenting, Adri N Mul,[...]. Cancer Res 2015
87
5

Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.
Weiyi Peng, Jie Qing Chen, Chengwen Liu, Shruti Malu, Caitlin Creasy, Michael T Tetzlaff, Chunyu Xu, Jodi A McKenzie, Chunlei Zhang, Xiaoxuan Liang,[...]. Cancer Discov 2016
705
5

Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.
Stefani Spranger, Daisy Dai, Brendan Horton, Thomas F Gajewski. Cancer Cell 2017
509
5

Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy.
Ovidiu C Andronesi, Grace S Kim, Elizabeth Gerstner, Tracy Batchelor, Aria A Tzika, Valeria R Fantin, Matthew G Vander Heiden, A Gregory Sorensen. Sci Transl Med 2012
255
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.